| # | Drug | Count |
|---|---|---|
| 0 | PALBOCICLIB | 57 |
| 1 | LETROZOLE | 42 |
| 2 | FULVESTRANT | 38 |
| 3 | DENOSUMAB | 26 |
| 4 | LETROZOLE TABLETS | 25 |
| 5 | EVEROLIMUS | 18 |
| 6 | EXEMESTANE | 18 |
| 7 | ANASTROZOLE | 17 |
| 8 | CAPECITABINE | 17 |
| 9 | ERGOCALCIFEROL | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0139 |
| 1 | ELACESTRANT | 15 | 0.0021 |
| 2 | FULVESTRANT | 38 | 0.0011 |
| 3 | BETAMETHASONE VALERATE FOAM | 4 | 0.0009 |
| 4 | EXEMESTANE | 18 | 0.0008 |
| 5 | LETROZOLE | 42 | 0.0007 |
| 6 | CAPIVASERTIB | 2 | 0.0007 |
| 7 | PALBOCICLIB | 57 | 0.0006 |
| 8 | ERGOCALCIFEROL | 16 | 0.0005 |
| 9 | GADOTERATE MEGLUMINE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 73 |
| 1 | Aromatase Inhibitor [EPC] | 62 |
| 2 | Estrogen Receptor Antagonist [EPC] | 53 |
| 3 | RANK Ligand Inhibitor [EPC] | 26 |
| 4 | mTOR Inhibitor Immunosuppressant [EPC] | 18 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 17 |
| 6 | Benzodiazepine [EPC] | 16 |
| 7 | Provitamin D2 Compound [EPC] | 16 |
| 8 | Corticosteroid [EPC] | 14 |
| 9 | beta-Adrenergic Blocker [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 53 | 0.0013 |
| 1 | Aromatase Inhibitor [EPC] | 62 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 3 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | Kinase Inhibitor [EPC] | 73 | 0.0001 |
| 6 | RANK Ligand Inhibitor [EPC] | 26 | 0.0001 |
| 7 | Androgen [EPC] | 2 | 0.0001 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 17 | 0.0001 |
| 9 | Sympathomimetic-like Agent [EPC] | 2 | 0.0001 |